Skip to Main Content

Principal Investigators

  • Amy Justice

    Consortium Principal Investigator

    C.N.H. Long Professor of Medicine (General Medicine) and Professor of Public Health (Health Policy); Co-Leader, Cancer Microbiology

    Dr. Justice is a Clinical Epidemiologist who has developed multiple large national cohorts based on data from the Veterans Affairs Healthcare System Electronic Medical Record enhanced with National Death Index and CMS data, patient completed surveys, DNA and tissue repositories, and stored pathology samples. She has two decades of experience in the processes required to clean, validate, and standardize raw EMR data and in its analysis using standard statistical methods, machine learning techniques, and cross cohort validations. The oldest and best known of her projects is the Veterans Aging Cohort Study (VACS). VACS is an ongoing, longitudinal study of >170,000 United States veterans with and without HIV infection continuously funded by National Institutes of Health (NIH) since 1996. She has developed and validated widely used indices including a prognostic index, the VACS Index, and a patient reported symptom index, the HIV Symptom Index. She is the principal investigator of the National Cancer Institute provocative questions grant HIV and Aging Mechanisms for Hepatocellular Cancer, has published over 400 peer reviewed manuscripts, and has presented work at the United Nations, The International AIDS Society, The Royal Medical College in London, the White House, and Congress. She is a member of the National Cancer Institute Ad hoc Subcommittee on HIV and AIDS Malignancy and the HIV and Aging Working Group, NIH Office of AIDS Research. She has recently joined the International Advisory Boards of Lancet HIV and Journal of the International AIDS Society.  

  • David Fiellin

    Affiliated PI/Member of Executive Committee

    Professor of Medicine (General Medicine), of Emergency Medicine, and of Public Health; Professor, Investigative Medicine; Director, Yale Program in Addiction Medicine; Director, Health Services and Research Core, Center for Interdisciplinary Research on AIDS (CIRA), Yale School of Public Health

    Dr. Fiellin has focused his scholarly work on the interface between primary care, HIV and addiction. He is a primary care internist Board Certified in Internal Medicine and Addiction Medicine.  He serves as the inaugural Director of the Yale Program in Addiction Medicine. He conducts research on the transfer of treatment strategies, including opioid agonist maintenance with methadone and buprenorphine, from specialized settings to office-based, primary care, Emergency Department and HIV specialty settings. He has served as Principal Investigator on multiple NIH-funded trials and directed the SAMHSA Physician Clinical Support System for buprenorphine. He is the Director of the Community Research and Implementation Core at Yale's Center for Interdisciplinary Research on AIDS. He has received awards including the Nyswander/Dole Award from the American Association for the Treatment of Opioid Dependence, the 2008 Annual Award from the American Society of Addiction Medicine, the Excellence in Mentorship Award from AMERSA and the Dan Anderson Research Award from the Hazelden-Betty Ford Foundation. He has served on the White House Office of National Drug Control Policy (ONDCP), Drug Control Research, Data, and Evaluation Advisory Committee, and the World Health Organization and United Nations Office on Drugs and Crime Technical Guideline Development Group for psychosocially assisted pharmacologic treatment of opioid dependence. He served as Chair of the Center for Substance Abuse Treatment's, Treatment Improvement Protocol on Treatment of Viral Hepatitis in Patients with Substance Use Disorders and on the Editorial Boards of Substance Abuse and the Journal of Addiction Medicine and is Co-Editor of Alcohol, Other Drugs & Health: Current Evidence and the Principles of Addiction Medicine, 4th, 5th and 6th Edition. He has served on the Board of Directors of the College on Problems of Drug Dependence and as Co-Chair of the Substance Abuse Task Force for the Society of General Internal Medicine.

  • Janet Tate

    Affiliated PI/Member of Executive Committee

    Assistant Professor; Director, Biostatistics Core, Veterans Aging Cohort Study (VACS); Co-Director, Risk Index Workgroup, Veterans Aging Cohort Study (VACS); Co-Director, Liver Core, Veterans Aging Cohort Study (VACS); Member, Publications Committee, Veterans Aging Cohort Study (VACS); Member, Executive Committee, Veterans Aging Cohort Study (VACS)

  • Cynthia Brandt

    Affiliated PI/Member of Executive Committee

    Professor of Emergency Medicine and of Anesthesiology

    Dr. Brandt completed a general Preventive Medicine residency at Madigan Army Medical Center in 1989 and a post-doctoral fellowship sponsored by the National Library of Medicine at Yale School of Medicine in 1997. She is board certified in Preventive Medicine and Clinical Informatics. Her research is interdisciplinary and focuses on issues related to the design, development and use of informatics tools in the domain of clinical research, as well as health services research.